Late entry of ‘Original’ Sanofi in the Plavix complex market
The original company has made a move. Sanofi, the developing company of ‘Plavix,’ is planning to enter the ‘aspirin’ complex market.
According to the industry concerned on the 11th, Sanofi-Aventis Korea is working on the domestic approval procedure for its products, called ‘Plavix A(clopidogrel+...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
